Today: 1 May 2026
Browse Category

Stock Market 9 January 2026

Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings

Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings

Arcutis Biotherapeutics shares fell 5.3% to $28.29 Friday after an early surge, tracking a shift in rate expectations following a soft U.S. jobs report. Broader biotech indexes rose. Investors are watching for Arcutis’ next earnings on Feb. 24 and an FDA decision on ZORYVE for children by June 29. The Fed’s late-January meeting remains a key focus for traders.
Intuitive Machines (LUNR) stock slides after Stifel downgrade as NASA moon rover decision nears

Intuitive Machines (LUNR) stock slides after Stifel downgrade as NASA moon rover decision nears

Intuitive Machines shares fell 3.8% to $18.88 Friday after Stifel downgraded the stock to “hold,” citing uncertainty over a pending NASA rover contract. The stock swung between $17.82 and $19.73 on heavy volume. NASA’s Lunar Terrain Vehicle award remains undecided. Investors are also watching for U.S. inflation data on Jan. 13 and company earnings on March 19.
Valero Energy stock dips on Piper Sandler target cut as Venezuela talks keep traders guessing

Valero Energy stock dips on Piper Sandler target cut as Venezuela talks keep traders guessing

Valero Energy shares fell 3% to $185.50 in mid-afternoon New York trading, while the S&P 500 ETF rose 0.8%. The White House is meeting with oil firms including Valero and Marathon to discuss possible investment in Venezuela’s energy sector. Valero plans to keep importing gasoline into Northern California after its Benicia refinery idles in April. Fourth-quarter results are due Jan. 29.
Why Equity Residential stock is sliding today: BMO downgrade meets a $400 million asset sale

Why Equity Residential stock is sliding today: BMO downgrade meets a $400 million asset sale

Equity Residential shares fell 3.8% to $60.46 after BMO Capital downgraded the stock, citing softening rental markets in major coastal cities. The drop followed news of a $400 million sale of three properties to JRK Property Holdings. Other large apartment REITs also traded lower. Investors are watching for upcoming U.S. inflation data and Equity Residential’s earnings on Feb. 2.
Freeport-McMoRan (FCX) stock jumps as copper firms and JPMorgan lifts target ahead of earnings

Freeport-McMoRan (FCX) stock jumps as copper firms and JPMorgan lifts target ahead of earnings

Freeport-McMoRan shares rose 4.4% to $56.59 Friday as copper prices climbed and JPMorgan raised its price target to $68. Goldman Sachs also lifted its copper forecast for the first half of 2026. Investors face a Jan 15 dividend record date and await the Jan 22 earnings report. Rio Tinto confirmed early merger talks with Glencore, sending sector shares moving.
9 January 2026
Valero (VLO) stock slides as Venezuela oil talks loom and an analyst trims a target

Valero (VLO) stock slides as Venezuela oil talks loom and an analyst trims a target

Valero shares dropped 3.2% to $185.16 Friday afternoon, underperforming other refiners as the White House met with oil firms, including Valero and Marathon, to discuss possible investment in Venezuela. Piper Sandler cut its Valero price target to $217. Oil prices rose amid global supply concerns. Investors await Valero’s Jan. 29 earnings report for margin and policy updates.
Linde stock ticks up as Feb. 5 earnings date lands — what investors watch next

Linde stock ticks up as Feb. 5 earnings date lands — what investors watch next

Linde plc shares gained 1% to $444.18 Friday ahead of its fourth-quarter results due Feb. 5. The company previously forecast Q4 adjusted EPS below analyst estimates and reported a 3% drop in EMEA volumes, a trend expected to continue. Rival Air Products also rose. Investors await updates on demand and pricing as the S&P 500 hit a record high and materials stocks advanced.
CRISPR Therapeutics stock slides after CFO share-sale filing; JPM conference next

CRISPR Therapeutics stock slides after CFO share-sale filing; JPM conference next

CRISPR Therapeutics shares fell 4.3% to $54.00 after a filing showed CFO Raju Prasad exercised and sold 29,700 shares under a preset trading plan. The move comes ahead of the company’s Jan. 12 slot at the J.P. Morgan Healthcare Conference and an expected mid-February earnings report. Gene-editing peers also traded lower. CASGEVY revenue and rollout remain key investor focus.
Vertiv stock rebounds after Thursday slide as jobs data steadies rate-cut bets

Vertiv stock rebounds after Thursday slide as jobs data steadies rate-cut bets

Vertiv Holdings shares rose 1.5% to $163.24 Friday afternoon, rebounding after a 6.3% drop Thursday tied to a tech-led market pullback. The move followed U.S. jobs data showing 50,000 jobs added in December and unemployment at 4.4%. Vertiv released a report Thursday highlighting new data center trends as AI drives demand. Traders are watching if the stock can hold above $160 ahead of next week’s inflation data.
9 January 2026
Why Abercrombie & Fitch stock is sliding today despite a UBS target hike

Why Abercrombie & Fitch stock is sliding today despite a UBS target hike

Abercrombie & Fitch shares dropped 3.7% to $125.09 Friday after a weaker U.S. jobs report and mixed consumer sentiment data. UBS raised its price target on the stock to $160, citing expected 2026 earnings growth. Payrolls rose by 50,000 in December, with job losses in retail. Investors await the Fed’s Jan. 27-28 meeting and Abercrombie’s next results, expected in early March.
9 January 2026
Nebius (NBIS) stock ticks up as AI names rebound — Rubin rollout and earnings are the next tests

Nebius (NBIS) stock ticks up as AI names rebound — Rubin rollout and earnings are the next tests

Nebius shares rose 1.2% to $98.48 Friday afternoon after swinging above $104 earlier in the session. The move followed gains in chip stocks and AI infrastructure names, with Nvidia up 0.5% and Applied Digital jumping over 17%. Traders are watching Nebius’ plans to offer Nvidia’s Rubin GPUs in late 2026 and its next earnings report, expected Feb. 18.

Stock Market Today

  • SanDisk Q3 Beats Expectations Amid Finite NAND Pricing Cycle
    May 1, 2026, 5:22 AM EDT. SanDisk reported phenomenal Q3 results, beating sales estimates by 20% and earnings by 50%. The company's gains are driven by supply constraints in NAND memory chips amid heightened AI demand, leading to soaring prices and exceptional profitability, with incremental gross margins above 90%. However, analysts caution that this pricing surge is finite, forecasting a supply glut in 2027-2028 from increased manufacturing capacity by SanDisk and competitors like SK Hynix and Samsung. This anticipated supply increase may trigger a sharp price correction, impacting SanDisk's future sales and profits despite ongoing AI demand. Investors should weigh short-term gains against longer-term risks of a down cycle.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 01.05.2026

1 May 2026
LIVEMarkets rolling coverageStarted: May 1, 2026, 12:00 AM EDTUpdated: May 1, 2026, 5:24 AM EDT SanDisk Q3 Beats Expectations Amid Finite NAND Pricing Cycle May 1, 2026, 5:22 AM EDT. SanDisk reported **phenomenal Q3 results**, beating sales estimates by 20% and earnings by 50%. The company's gains are driven by **supply constraints** in NAND memory chips amid heightened AI demand, leading to soaring prices and exceptional profitability, with incremental gross margins above 90%. However, analysts caution that this pricing surge is **finite**, forecasting a supply glut in 2027-2028 from increased manufacturing capacity by SanDisk and competitors like SK Hynix and
Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Go toTop